Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 7 de 7
Filtrer
1.
Pediatr Blood Cancer ; 69(8): e29642, 2022 08.
Article de Anglais | MEDLINE | ID: mdl-35403812

RÉSUMÉ

INTRODUCTION: The International Society of Paediatric Oncology-Paediatric Oncology in Developing Countries (SIOP-PODC) group recommended graduated-intensity retinoblastoma treatment for children in low- and middle-income countries with limited local resources. AIM: The aim was to improve outcome of children with retinoblastoma by means of a treatment protocol for low-income settings as recommended by the SIOP-PODC recommendation in Cameroon. METHODS: Children diagnosed with retinoblastoma between 2012 and 2016 were treated in two Baptist Mission hospitals in Cameroon, staging according to the International Retinoblastoma Staging System. Treatment included local therapy and combination chemotherapy (vincristine, cyclophosphamide, and doxorubicin) with or without surgery as per SIOP-PODC guidelines for low-income countries. Endpoint was survival at 24 months. Kaplan-Meier curves with log-rank (Mantel-Cox) chi-square (χ2 ) with respective p-values were prepared. RESULTS: Eighty-two children were included, of whom 79.3% had unilateral disease. The majority were males (61.0%) with median age 24 months (range 1-112 months; standard deviation [SD] 19). Limited disease was diagnosed in 58.5%, metastatic disease in 35.4%, and unknown stage in 6.1%. Overall survival (OS) was 50.0% at 24 months post diagnosis, but 68.8% for limited disease. Estimated cumulative survival at 24 months was 0.528 (standard error [SE] 0.056). Causes of death included disease progression/relapses (60.5%), neutropenic sepsis (15.9%), unknown causes (18.4%), unrelated infection (2.6%), and death post surgery (2.6%). Stage was significantly associated with OS (p < .001). CONCLUSION: Stage was the most significant factor for good OS and demonstrated the efficacy and feasibility of the SIOP-PODC-proposed management guidelines for retinoblastoma in a lower middle-income setting.


Sujet(s)
Tumeurs de la rétine , Rétinoblastome , Protocoles de polychimiothérapie antinéoplasique/usage thérapeutique , Cameroun , Enfant , Enfant d'âge préscolaire , Protocoles cliniques , Pays en voie de développement , Femelle , Humains , Nourrisson , Mâle , Récidive tumorale locale/traitement médicamenteux , Tumeurs de la rétine/traitement médicamenteux , Rétinoblastome/traitement médicamenteux , Résultat thérapeutique
2.
J Trop Pediatr ; 67(3)2021 07 02.
Article de Anglais | MEDLINE | ID: mdl-33020840

RÉSUMÉ

Effective cancer registration is required for the development of cancer management policies, but is often deficient in the developing world. In 2008 cancer registration was set up Banso Baptist Hospital and Mbingo Baptist Hospital in the Northwest region of Cameroon, using the Pediatric Oncology Networked Database (POND). The objective of this study was to analyze the POND registry data for patients with cancer aged 0-15 years for the period 2004-15. A total of 1029 malignancies were recorded in children 0-15 years in the study period. The male-to-female ratio was 1.4:1. The median age at diagnosis was 7.22 years. The most common malignancies were lymphomas followed by nephroblastoma, retinoblastoma, rhabdomyosarcoma and Kaposi sarcoma. There were more Burkitt lymphomas cases between 2004 and 2009 than between 2010 and 2015, while the number of cases rose for other diagnoses like retinoblastoma and nephroblastoma. This report has demonstrated how pediatric oncology registration can be implemented, improved and sustained in a low- and middle-income country setting with limited resources. Using the data, these hospitals can improve their treatment planning and ensure the availability of essential chemotherapy for childhood cancers.


Sujet(s)
Lymphome de Burkitt , Tumeurs , Rhabdomyosarcome , Cameroun/épidémiologie , Enfant , Femelle , Hôpitaux , Humains , Incidence , Mâle , Tumeurs/épidémiologie , Enregistrements
3.
OTO Open ; 3(1): 2473974X18818415, 2019.
Article de Anglais | MEDLINE | ID: mdl-31236529

RÉSUMÉ

OBJECTIVE: Oral human papillomavirus (HPV) infection is the precursor for a growing subset of oropharyngeal squamous cell carcinomas (OPSCCs) in the developed world. This study was designed to characterize oral HPV infection and OPSCC in a region with high rates of HPV-driven cervical cancer. STUDY DESIGN: Cross-sectional cohort study, retrospective case series. SETTING: Northwest Cameroon referral hospital. SUBJECTS AND METHODS: Individuals infected with human immunodeficiency virus attending an outpatient clinic were evaluated for oral HPV infection with oral swabs or rinses that were tested for 51 HPV types. HNSCCs diagnosed and/or treated at the same hospital from 2011 to 2017 were retrospectively reviewed to ascertain demographic and tumor characteristics, and available OPSCCs were tested for HPV. RESULTS: The oral HPV infection study population comprised 101 participants. Most (69%) were female and never-smokers (84%). Participants had median 4 lifetime sexual partners (interquartile range, 3-7; range, 1-100). Five participants (5%) had oral HPV infection; one had 2 HPV types. HPV types detected were HPV68 (n = 2), HPV82 (n = 2), HPV32 (n = 1), and unknown (n = 1). No significant demographic or behavioral differences were detected among individuals with vs without oral HPV infection. OPSCCs comprised just 8% (n = 11) of 131 HNSCCs in the retrospective study population. Two of 7 OPSCCs were HPV positive. CONCLUSION: The low prevalence of OPSCC observed in northwest Cameroon together with the rarity of oral HPV infection suggests low rates of HPV-driven oropharyngeal carcinogenesis in the region. Future research should examine how geographic differences in oral HPV infection are influenced by cultural norms and affect HPV-OPSCC epidemiology.

4.
Pan Afr Med J ; 29: 178, 2018.
Article de Anglais | MEDLINE | ID: mdl-30050642

RÉSUMÉ

INTRODUCTION: Gastrointestinal endoscopy is an important modality for diagnosis and treatment of gastrointestinal disease, but there are limited data regarding the diagnostic yield of endoscopy in Cameroon and changes in the prevalence of endoscopic findings over time. Our aims were to describe the diagnostic utility of esophagogastroduodenoscopy (EGD) and colonoscopy, the impact of periodic on-site mentorship on cecal intubation rate and changes in the prevalence of common upper gastrointestinal findings when compared to a similar report from our region published in 1990. METHODS: Retrospective review of all EGD and colonoscopy procedures performed during 2015 at a regional referral hospital in North West Region, Cameroon, with comparison to EGD findings reported by Dent and colleagues in 1990. During the year 3 endoscopists provided periodic colonoscopy mentorship. RESULTS: Among 1,371 EGDs, abnormalities were found in 59.7% and therapeutic interventions (most commonly esophageal stricture dilation or band ligation of varices) were performed in 137 (10%). When compared to 25 years previously, peptic ulcer disease was less common and esophagitis was more common (p < 0.0001; p < 0.0001). The prevalence of malignancy (2.2%) was similar. Among 380 colonoscopies diagnostic findings were seen in 60.5%, including colorectal malignancies in 5.8%. Cecal intubation rate improved from 32% to 89% during the one-year study period. CONCLUSION: EGD and colonoscopy have a diagnostic yield of about 60% in symptomatic patients in North West Region, Cameroon. When compared to 1990 peptic ulcer disease was less common and esophagitis was more common. Periodic on-site mentorship was associated with improved physician performance of colonoscopy.


Sujet(s)
Coloscopie/méthodes , Endoscopie digestive/méthodes , Maladies gastro-intestinales/diagnostic , Mentors , Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Cameroun/épidémiologie , Enfant , Enfant d'âge préscolaire , Tumeurs colorectales/diagnostic , Tumeurs colorectales/épidémiologie , Oesophagite/diagnostic , Oesophagite/épidémiologie , Femelle , Maladies gastro-intestinales/épidémiologie , Humains , Mâle , Adulte d'âge moyen , Ulcère peptique/diagnostic , Ulcère peptique/épidémiologie , Prévalence , Études rétrospectives , Facteurs temps , Jeune adulte
5.
J Clin Aesthet Dermatol ; 10(1): 47-56, 2017 Jan.
Article de Anglais | MEDLINE | ID: mdl-28210381

RÉSUMÉ

Teledermatology is a rapidly expanding niche within telemedicine still in its infancy. It has become increasingly more feasible in recent years with the expansion of information and communication technologies. Here, the authors present the details of their collaboration and propose a model for constructing a teledermatology network. In the year 2014, the authors' Dermatopathology institute in Torrance, California, partnered with Mbingo Baptist Hospital, a tertiary referral center in Cameroon, Africa. During this time, 145 cases were received. The authors present highlights of specific cases as well as the strengths and challenges encountered. They have found the use of the store and forward method to be an effective tool with an acceptable concordance rate. With basic bandwidth speeds and images taken with smart devices shared via email, providers are given the unique opportunity to provide specialty care and alleviate disease burden where dermatology and dermatopathology resources are scarce.

6.
Arch Pathol Lab Med ; 128(11): 1270-3, 2004 Nov.
Article de Anglais | MEDLINE | ID: mdl-15504062

RÉSUMÉ

The deposition of amyloid as a distinct, clinically apparent mass is uncommon, particularly in soft tissues. Among reported sites of soft tissue amyloidomas, the extremities are quite rare. Amyloid tumors can mimic malignant neoplasms both clinically and radiologically. We report a case of AA amyloidoma presenting in the deltoid region with radiological features suggesting sarcoma. Cytomorphology from fine-needle aspiration material, tissue histology, and appearance by magnetic resonance imaging are described. The literature on soft tissue amyloidoma is reviewed.


Sujet(s)
Amyloïdose/diagnostic , Sarcomes/diagnostic , Tumeurs des tissus mous/diagnostic , Sujet âgé , Bras/anatomopathologie , Diagnostic différentiel , Humains , Mâle , Muscles squelettiques/anatomopathologie
7.
Arch Pathol Lab Med ; 128(2): e25-8, 2004 Feb.
Article de Anglais | MEDLINE | ID: mdl-14736268

RÉSUMÉ

We report an unusual case of biliary cystadenocarcinoma with oncocytic differentiation. The patient was a 43-year-old woman who presented with right upper quadrant pain. Imaging revealed a 16 x 10 x 10-cm, heterogenous, right hepatic mass with extension into the right atrium. Surgical resection revealed a papillary neoplasm of malignant cells with atypical hyperchromatic nuclei and prominent nucleoli lining fibrovascular cores. Mesenchymal stroma was not present. The majority of the epithelial cells had abundant eosinophilic granular cytoplasm, consistent with oncocytic differentiation. There was extensive stromal and hepatic parenchymal invasion. Immunohistochemical staining revealed a "biliary pattern" of cytokeratin subset immunoreactivity, with positivity for cytokeratin 7 and an absence of staining with cytokeratin 20. The tumor was negative for mucin, carcinoembryonic antigen, alpha-fetoprotein, calretinin, CD31, and chromogranin. There was granular cytoplasmic staining with phosphotungstic acid hematoxylin, consistent with the presence of abundant mitochondria. Electron microscopy revealed abundant mitochondria within the neoplastic cells. This case is quite unusual because female patients only rarely lack the characteristic ovarian-like mesenchymal stroma of biliary cystadenomas/cystadenocarcinomas. Furthermore, to our knowledge, oncocytic differentiation in this neoplasm has been reported previously on only 2 occasions. The biologic behavior and prognostic significance, if any, of the lack of mesenchymal stroma in female patients or the presence of oncocytic differentiation remains to be further elucidated as more of these cases are described.


Sujet(s)
Tumeurs des voies biliaires/anatomopathologie , Cystadénocarcinome/anatomopathologie , Cellules oxyphiles/anatomopathologie , Adulte , Tumeurs des voies biliaires/diagnostic , Tumeurs des voies biliaires/ultrastructure , Différenciation cellulaire , Cystadénocarcinome/diagnostic , Cystadénocarcinome/ultrastructure , Femelle , Histocytochimie , Humains , Mitochondries/ultrastructure
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE